{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Santé masculine : Questions médicales les plus fréquentes",
"headline": "Santé masculine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Santé masculine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-07",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Santé masculine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Santé",
"url": "https://questionsmedicales.fr/mesh/D006262",
"about": {
"@type": "MedicalCondition",
"name": "Santé",
"code": {
"@type": "MedicalCode",
"code": "D006262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N01.400"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Santé masculine",
"alternateName": "Men's Health",
"code": {
"@type": "MedicalCode",
"code": "D054526",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Louise M Waite",
"url": "https://questionsmedicales.fr/author/Louise%20M%20Waite",
"affiliation": {
"@type": "Organization",
"name": "Centre of Education and Research on Ageing, Ageing and Alzheimer's Institute, University of Sydney and Concord Hospital, Australia."
}
},
{
"@type": "Person",
"name": "Fiona M Blyth",
"url": "https://questionsmedicales.fr/author/Fiona%20M%20Blyth",
"affiliation": {
"@type": "Organization",
"name": "School of Public Health, University of Sydney, Australia."
}
},
{
"@type": "Person",
"name": "Vasi Naganathan",
"url": "https://questionsmedicales.fr/author/Vasi%20Naganathan",
"affiliation": {
"@type": "Organization",
"name": "Centre of Education and Research on Ageing, Ageing and Alzheimer's Institute, University of Sydney and Concord Hospital, Australia."
}
},
{
"@type": "Person",
"name": "Robert G Cumming",
"url": "https://questionsmedicales.fr/author/Robert%20G%20Cumming",
"affiliation": {
"@type": "Organization",
"name": "School of Public Health, University of Sydney, Australia."
}
},
{
"@type": "Person",
"name": "David J Handelsman",
"url": "https://questionsmedicales.fr/author/David%20J%20Handelsman",
"affiliation": {
"@type": "Organization",
"name": "ANZAC Research Institute, University of Sydney and Concord Hospital, Australia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Vaccination barriers and opportunities at syringe services programs in the United States, June-August 2021-A cross-sectional survey.",
"datePublished": "2022-06-16",
"url": "https://questionsmedicales.fr/article/35753280",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.drugalcdep.2022.109540"
}
},
{
"@type": "ScholarlyArticle",
"name": "The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.",
"datePublished": "2023-02-02",
"url": "https://questionsmedicales.fr/article/36732773",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12954-023-00742-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model.",
"datePublished": "2024-08-29",
"url": "https://questionsmedicales.fr/article/39208211",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0308102"
}
},
{
"@type": "ScholarlyArticle",
"name": "Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care.",
"datePublished": "2024-06-01",
"url": "https://questionsmedicales.fr/article/38824597",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12954-024-01019-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Houselessness and syringe service program utilization among people who inject drugs in eight rural areas across the USA: a cross-sectional analysis.",
"datePublished": "2023-10-26",
"url": "https://questionsmedicales.fr/article/37880724",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12954-023-00892-w"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Caractéristiques de la population",
"item": "https://questionsmedicales.fr/mesh/D011154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé",
"item": "https://questionsmedicales.fr/mesh/D006262"
},
{
"@type": "ListItem",
"position": 4,
"name": "Santé masculine",
"item": "https://questionsmedicales.fr/mesh/D054526"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Santé masculine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Santé masculine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Santé masculine",
"description": "Comment diagnostiquer l'hypertrophie bénigne de la prostate ?\nQuels tests pour évaluer la santé sexuelle masculine ?\nComment détecter le cancer testiculaire ?\nQuels signes indiquent une maladie cardiovasculaire ?\nComment évaluer le risque de diabète chez les hommes ?",
"url": "https://questionsmedicales.fr/mesh/D054526?mesh_terms=Needle-Exchange+Programs&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Santé masculine",
"description": "Quels sont les symptômes de la dysfonction érectile ?\nComment reconnaître un cancer de la prostate ?\nQuels signes indiquent une dépression chez les hommes ?\nQuels symptômes d'une maladie cardiaque chez les hommes ?\nQuels symptômes d'un déséquilibre hormonal ?",
"url": "https://questionsmedicales.fr/mesh/D054526?mesh_terms=Needle-Exchange+Programs&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Santé masculine",
"description": "Comment prévenir le cancer de la prostate ?\nQuelles mesures pour prévenir la dysfonction érectile ?\nComment réduire le risque de maladies cardiaques ?\nQuelles sont les recommandations pour la santé mentale ?\nComment prévenir le diabète de type 2 ?",
"url": "https://questionsmedicales.fr/mesh/D054526?mesh_terms=Needle-Exchange+Programs&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Santé masculine",
"description": "Quels traitements pour la dysfonction érectile ?\nComment traiter l'hypertrophie bénigne de la prostate ?\nQuelles sont les options pour le cancer testiculaire ?\nComment traiter la dépression chez les hommes ?\nQuels traitements pour les maladies cardiovasculaires ?",
"url": "https://questionsmedicales.fr/mesh/D054526?mesh_terms=Needle-Exchange+Programs&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Santé masculine",
"description": "Quelles complications de la dysfonction érectile ?\nQuelles complications du cancer de la prostate ?\nQuels risques associés à l'hypertrophie bénigne de la prostate ?\nQuelles complications des maladies cardiovasculaires ?\nQuelles complications du diabète non contrôlé ?",
"url": "https://questionsmedicales.fr/mesh/D054526?mesh_terms=Needle-Exchange+Programs&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Santé masculine",
"description": "Quels sont les facteurs de risque pour le cancer de la prostate ?\nQuels facteurs de risque pour les maladies cardiaques ?\nQuels facteurs de risque pour la dysfonction érectile ?\nQuels sont les facteurs de risque de dépression chez les hommes ?\nQuels facteurs de risque pour le diabète de type 2 ?",
"url": "https://questionsmedicales.fr/mesh/D054526?mesh_terms=Needle-Exchange+Programs&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hypertrophie bénigne de la prostate ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen physique, un dosage du PSA et une échographie peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer la santé sexuelle masculine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests hormonaux, un examen physique et des questionnaires sur la fonction érectile sont courants."
}
},
{
"@type": "Question",
"name": "Comment détecter le cancer testiculaire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'auto-examen, l'échographie et les marqueurs tumoraux sont essentiels pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une maladie cardiovasculaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs thoraciques, essoufflement et fatigue peuvent signaler une maladie cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque de diabète chez les hommes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test de glycémie à jeun et une évaluation des facteurs de risque sont recommandés."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la dysfonction érectile ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Difficulté à obtenir ou maintenir une érection, souvent accompagnée de stress ou d'anxiété."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un cancer de la prostate ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des difficultés urinaires, des douleurs pelviennes et du sang dans les urines."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une dépression chez les hommes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, irritabilité, perte d'intérêt et changements d'appétit sont des signes courants."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une maladie cardiaque chez les hommes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs thoraciques, essoufflement, palpitations et fatigue excessive peuvent être des indicateurs."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'un déséquilibre hormonal ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Changements d'humeur, fatigue, prise de poids et diminution de la libido peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment prévenir le cancer de la prostate ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine, l'exercice régulier et des examens médicaux réguliers sont conseillés."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour prévenir la dysfonction érectile ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un poids santé, éviter le tabac et gérer le stress sont des mesures préventives."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de maladies cardiaques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter une alimentation équilibrée, faire de l'exercice et contrôler la pression artérielle aide."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour la santé mentale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pratiquer la pleine conscience, maintenir des relations sociales et consulter un professionnel si nécessaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir le diabète de type 2 ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine, l'exercice régulier et le contrôle du poids sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la dysfonction érectile ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les options incluent des médicaments, des dispositifs sous vide et des thérapies psychologiques."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hypertrophie bénigne de la prostate ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, des thérapies minimales invasives et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Quelles sont les options pour le cancer testiculaire ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Chirurgie, chimiothérapie et radiothérapie sont les principales options de traitement."
}
},
{
"@type": "Question",
"name": "Comment traiter la dépression chez les hommes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie, les médicaments antidépresseurs et le soutien social."
}
},
{
"@type": "Question",
"name": "Quels traitements pour les maladies cardiovasculaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent inclure des médicaments, des changements de mode de vie et des interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Quelles complications de la dysfonction érectile ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner des problèmes relationnels, une dépression et une diminution de la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quelles complications du cancer de la prostate ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut inclure des problèmes urinaires, des douleurs chroniques et des effets secondaires des traitements."
}
},
{
"@type": "Question",
"name": "Quels risques associés à l'hypertrophie bénigne de la prostate ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut causer des infections urinaires, des calculs vésicaux et des complications chirurgicales."
}
},
{
"@type": "Question",
"name": "Quelles complications des maladies cardiovasculaires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peuvent inclure des crises cardiaques, des AVC et des insuffisances cardiaques."
}
},
{
"@type": "Question",
"name": "Quelles complications du diabète non contrôlé ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peut entraîner des neuropathies, des maladies rénales et des problèmes de vision."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour le cancer de la prostate ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Âge avancé, antécédents familiaux et obésité sont des facteurs de risque connus."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour les maladies cardiaques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Hypertension, diabète, tabagisme et sédentarité augmentent le risque de maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la dysfonction érectile ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Diabète, maladies cardiovasculaires, stress et certains médicaments peuvent contribuer."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de dépression chez les hommes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Antécédents familiaux, stress chronique et problèmes relationnels peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le diabète de type 2 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Obésité, sédentarité, antécédents familiaux et alimentation déséquilibrée sont des facteurs clés."
}
}
]
}
]
}
Syringe services programs (SSPs) are an important venue for reaching people who inject drugs (PWID) to offer preventive services; however, not all SSPs offer vaccinations. We aimed to describe barrier...
During June-August 2021, we conducted a descriptive, cross-sectional survey of SSP providers in the United States. SSPs were recruited from national listservs using purposive sampling to ensure geogra...
In total, 105 SSPs from 34 states responded to the survey; 46 SSPs (43.8%) offered on-site vaccinations. SSPs without on-site vaccinations were more likely operated by community-based organizations (8...
Addressing missed opportunities for offering vaccinations to PWID who use SSPs will require increased numbers of on-site personnel licensed to administer vaccines and additional training, vaccination ...
Syringe service programs (SSPs) deliver critical harm reduction services to people who inject drugs (PWID). Some SSPs in New York State received enhanced funding to provide additional services to comb...
Between July 2020 and September 2020, we performed eleven semi-structured virtual interviews with staff from three Health Hub SSPs and three stand-alone SSPs. The interviews explored the effect of the...
Due to the COVID-19 pandemic, some SSPs temporarily shut down while others limited their hours of operation. SSPs modified their service delivery to maintain syringe services and naloxone distribution...
In response to the COVID-19 pandemic, SSPs demonstrated innovation, adaptability, and togetherness. Despite the challenges posed by the pandemic, SSPs continued to be key players in maintaining access...
The main mode of transmission of Hepatitis C in North America is through injection drug use. Availability of accessible care for people who inject drugs is crucial for achieving hepatitis C eliminatio...
The objective of this analysis is to compare the changes in injection drug use frequency and high-risk injection behaviors in participants who were randomized to accessible hepatitis c care versus usu...
Participants who were hepatitis C virus RNA positive and had injected drugs in the last 90 days were enrolled and randomized 1:1 to an on-site, low threshold accessible care arm or a standard, referra...
The primary outcomes of this secondary analysis are the changes in the frequency of injection drug use, high-risk injection behaviors, and receiving medication for opioid use disorder in the last 30 d...
A total of 165 participants were enrolled in the study, with 82 participants in the accessible care arm and 83 participants in the usual care arm. Participants in the accessible care arm were found to...
Hepatitis C treatment through an accessible care model resulted in statistically higher rates of decrease in injection drug use frequency in people who inject drugs....
Syringe services programs (SSPs) are critical healthcare access points for people with opioid use disorder (OUD) who face treatment utilization barriers. Co-locating care for common psychiatric comorb...
Study participants were administered the PTSD Checklist for the DSM-5 (PCL-5) and asked about sociodemographic characteristics, current drug use, OUD and PTSD treatment histories, and desire for futur...
Of the 139 participants surveyed, 138 experienced at least one potentially traumatic event and were included in the present analysis. The sample was primarily male (n = 108, 78.3%), of Hispanic or Lat...
Study findings point to the ubiquity of PTSD in people with OUD who visit SSPs, large gaps in PTSD care, and the potential for harm reduction settings like SSPs to reach people underserved by the heal...
Research conducted in urban areas has highlighted the impact of housing instability on people who inject drugs (PWID), revealing that it exacerbates vulnerability to drug-related harms and impedes syr...
PWID were recruited using respondent-driven sampling for a cross-sectional survey that queried self-reported drug use and SSP utilization in the prior 30 days, houselessness in the prior 6 months and ...
Among 2394 rural PWID, 56.5% had experienced houselessness in the prior 6 months, and 43.5% reported past 30-day SSP use. PWID who had experienced houselessness were more likely to report using an SSP...
This study provides evidence that rural PWID who experience houselessness utilize SSPs at similar or higher rates as their housed counterparts. However, housing instability may pose barriers to more f...
Kidney transplant candidates may be incompatible with their intended living donors because of the presence of antibodies against HLA and/or ABO. To increase the possibility of finding an acceptable ki...
This is a retrospective review of our experiences from the first 4 y of the STEP program, including details about the match runs, performed transplantations, and recipient outcomes within the program....
During 2019-2022, 11 match runs and 4 reruns were performed. In total, 114 pairs and 6 anonymous donors participated in these match runs. Fifty-one pairs (45%) participated in 1 match run, 31 pairs (2...
The STEP program offers sensitized patients an enlarged pool of living donors and a chance of a compatible international living donor, resulting in an increased number of total transplantations. Curre...
Syringe services programs (SSPs) provide critical evidence-based public health services that decrease harms from drug use for people who use drugs (PWUD). Many SSPs have experienced significant and ev...
Participating sites, selected from a national sample of SSPs, completed a semi-structured interview via teleconference and brief survey evaluating the impacts of COVID-19 on program operations. Data c...
27 SSPs completed study-related interviews and surveys between February 2021 - April 2021. One year into the pandemic, SSPs reported continuing to adapt approaches to syringe distribution in response ...
These data illuminate persistent and cascading risks of isolation, reduced access to services, and limited engagement with program participants that resulted from COVID-19 and continue to create barri...
Among people who inject drugs (PWID), obtaining syringes via syringe services programs (SSPs) and pharmacies reduces injection sharing practices associated with hepatitis C virus (HCV). Whether indire...
Data are from a cross-sectional study of adults who use drugs recruited from eleven rural counties in New Hampshire, Vermont, and Massachusetts using respondent-driven sampling (2018-2019). Study staf...
Among 397 PWID, the most common primary syringe source was "other" (33%), then pharmacies (27%), SSPs (22%), and secondary exchange (18%). In multivariable models, compared with those obtaining most s...
PWID in rural New England largely relied on informal syringe sources (i.e., secondary exchange or sources besides SSPs/pharmacies). Those obtaining most syringes from an SSP or pharmacy were less like...
International exchange programs between physician assistants (PAs) and other advanced practice providers (APPs) from different countries can facilitate opportunities for global health training and exp...
Ten APPs in the United States anonymously answered an 8-item survey on their experience in an international exchange program with APPs in the Netherlands with a 100% response rate. The survey containe...
All respondents agree or strongly agree that the program contributed to APP growth in cultural competence and professional development. Eighty percent of respondents found APP practices in the United ...
Survey results examined in this article underscore how an international exchange program can not only enrich individual professional paths but also positively contribute to the broader global health c...
Fentanyl has played a significant role in the opioid crisis, proving to be a persistent problem due to its analgesic effects and addictive nature. Consequently, fentanyl analogs have been identified a...